⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24196439 | 0.76 | — | — | |
| SCHEMBL916367 | 0.75 | — | — | |
| SCHEMBL17672 | 0.75 | — | — | |
| SCHEMBL289440 | 0.72 | — | — | |
| SCHEMBL11874135 | 0.72 | — | — | |
| SCHEMBL28799562 | 0.72 | — | — | |
| SCHEMBL776997 | 0.72 | — | — | |
| SCHEMBL24593068 | 0.72 | — | — | |
| SCHEMBL3085455 | 0.72 | — | — | |
| SCHEMBL10418279 | 0.72 | ALDH1A1 (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260109711-A1 | MACROCYCLIC SULFONAMIDE MODULATORS | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2026-04-23 | — | — | US | disclosed |
| CN-106574261-A | Improved Fc-binding protein, method for producing said protein, antibody adsorbent using said protein, and method for separating antibody using said adsorbent | 东曹株式会社 | 2017-04-19 | — | — | CN | disclosed |
| US-8178677-B2 | Hydroxyalkyl substituted imidazoquinolines | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2012-05-15 | — | — | US | disclosed |
| CN-1780821-A | Heterocyclic kinase inhibitors. | ABBOTT LAB (US) | 2006-05-31 | — | — | CN | disclosed |
| EP-0221175-B1 | THERMALLY INDUCED PHASE SEPARATION IMMUNOASSAY | GENETIC SYSTEMS CORPORATION (US) | 1991-02-27 | — | — | EP | disclosed |